LOGIN  |  REGISTER
Cue Biopharma

Recent Insider Transactions - Enliven Therapeutics (NASDAQ: ELVN)

Follow NASDAQ:ELVN Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ELVN Enliven Therapeutics
Patel Anish / officer: CHIEF OPERATING OFFICER
01/07/2025
Sell
$24.17
6,577
$159K
336,734
NASDAQ ELVN Enliven Therapeutics
Patel Anish / officer: CHIEF OPERATING OFFICER
01/07/2025
Sell
$24.60
90
$2K
336,644
NASDAQ ELVN Enliven Therapeutics
Patel Anish / officer: CHIEF OPERATING OFFICER
01/07/2025
Sell
$2.48
9,000
$22K
44,342
NASDAQ ELVN Enliven Therapeutics
Patel Anish / officer: CHIEF OPERATING OFFICER
01/07/2025
Buy
$2.48
9,000
$22K
21,700
NASDAQ ELVN Enliven Therapeutics
Patel Anish / officer: CHIEF OPERATING OFFICER
01/07/2025
Buy
$2.48
2,000
$5K
12,700
NASDAQ ELVN Enliven Therapeutics
Patel Anish / officer: CHIEF OPERATING OFFICER
01/07/2025
Buy
$1.12
10,700
$12K
10,700
NASDAQ ELVN Enliven Therapeutics
Patel Anish / officer: CHIEF OPERATING OFFICER
01/07/2025
Sell
$24.15
20,260
$489K
1,440
NASDAQ ELVN Enliven Therapeutics
Patel Anish / officer: CHIEF OPERATING OFFICER
01/07/2025
Sell
$2.48
2,000
$5K
827
NASDAQ ELVN Enliven Therapeutics
Patel Anish / officer: CHIEF OPERATING OFFICER
01/07/2025
Sell
$1.12
10,700
$12K
67
NASDAQ ELVN Enliven Therapeutics
Patel Anish / officer: CHIEF OPERATING OFFICER
01/07/2025
Sell
$24.56
1,440
$35K
0
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
12/13/2024
Sell
$2.48
13,000
$32K
155,556
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
01/03/2025
Sell
$2.48
1,000
$2K
150,306
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
01/03/2025
Buy
$2.48
1,000
$2K
14,000
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
01/03/2025
Sell
$25.04
1,000
$25K
13,000
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
12/13/2024
Buy
$2.48
13,000
$32K
13,000
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
12/27/2024
Sell
$2.48
3,350
$8K
165,206
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
12/30/2024
Sell
$2.48
900
$2K
164,306
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
12/27/2024
Buy
$2.48
3,350
$8K
3,350
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
12/30/2024
Buy
$2.48
900
$2K
900
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
12/27/2024
Sell
$22.15
3,350
$74K
0
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
12/30/2024
Sell
$22.51
900
$20K
0
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
11/27/2024
Sell
$2.48
5,250
$13K
168,556
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
11/27/2024
Buy
$2.48
5,250
$13K
5,250
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
11/27/2024
Sell
$24.78
4,250
$105K
1,000
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
11/27/2024
Sell
$25.38
1,000
$25K
0

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous